Announcements

Rebecca Johnson to Present Dissertation Seminar “SR-B1 Directed rHDL Nanoparticles as a Drug Delivery System against Triple Negative Breast Cancer”
April 8, 2016
 

In partial fulfillment of the requirements for the Doctor of Philosophy degree in the Graduate School of Biomedical Sciences, Rebecca Johnson will present a seminar entitled, “SR-B1 Directed rHDL Nanoparticles as a Drug Delivery System against Triple Negative Breast Cancer,” on April 15, 2016, at 2:30 p.m. in EEAD-506. The campus community is invited to attend. A private defense with the advisory committee will immediately follow the seminar.

Ms. Johnson is a doctoral candidate in Biochemistry and Cancer Biology, under the supervision of Andras Lacko, Ph.D., Institute for Cardiovascular and Metabolic Disease.